We are live on
!
Find out more
NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
Fund managers haven’t disclosed any holdings of NYMX yet.
NYMX Hedge Fund Activity: Q1 2026 in Review
1 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2026, worth a combined $2.46K — up 74% from $1.41K a quarter earlier.
Fund positioning in NYMX was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held Nymox Pharmaceutical Corp (NYMX) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $2.46K of Nymox Pharmaceutical Corp stock for Q1 2026, up 74% quarter-over-quarter.
- 0 funds opened new Nymox Pharmaceutical Corp positions in Q1 2026 and 0 closed out.
Based on aggregated 13F filings for Q1 2026.